Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021 — Ralf Weiskirchen (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
RW
Shared by
Ralf Weiskirchen
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Editorial Material
2022
en
Authors
RW
Ralf Weiskirchen
AI
Angelo A. Izzo
Abstract
Related publications
Letter
2019
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Ralf Weiskirchen
Editorial Material
2021
Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
Ralf Weiskirchen
,
Dario Sorrentino
,
Wolfgang Stremmel
1 min read
EDITORIAL article Front. Pharmacol., 05 April 2022Sec. Gastrointestinal and Hepatic Pharmacology https://doi.org/10.3389/fphar.2022.890212
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Editorial Material
2023
Editorial: High altitude medicinal plants and their bioactive compounds for the prevention of oxidative stress-induced diseases and disorders
Prabhakar Semwal
,
Abdur Rauf
,
Jesus Simal Gandara
Editorial Material
2022
Editorial: Hypoxia in cardiovascular disease
Grzegorz Bilo
,
Hannes Gatterer
,
Camilla Torlasco
,
Francisco C. Villafuerte
,
Gianfranco Parati
Editorial Material
2022
Editorial: Stress and Neurodevelopment
Panagiota Pervanidou
,
Agorastos Agorastos
,
George Chrousos
Discussion(0)
No comments yet. Be the first to comment.